Sponsor study identifier
interventional
5
1 country
1
Study Start
September 1, 2019
Actual (reported)Primary Completion
June 30, 2020
Actual (reported)Study Completion
June 30, 2020
Actual (reported)This study seeks to determine whether a patient navigator can help improve follow up care after a stool test shows the presence of blood or other abnormal markers.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 30, 2020
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 24, 2019
Actual (reported)January 28, 2019
Actual (reported)September 1, 2019
Actual (reported)June 30, 2020
Actual (reported)June 30, 2020
Actual (reported)Number of participants completing a follow-up colonoscopy procedure
Feasibility of a navigator based intervention to improve follow up will be determined by comparing the colonoscopy completion rate to historical controls. This will be measured as number of participants completing a follow-up colonoscopy procedure.
Up to 6 months from start of study
Participant meets the patient navigator at their colonoscopy appointment and discusses any problems they experienced in getting the colonoscopy done. Participant will tell navigator in their own words their experience and whether they faced any barriers to scheduling and colonoscopy completion.
Intervention will utilize staff at the Seidman Cancer Center who are trained in patient navigation and have experience in navigating patients for breast cancer screening as well as sickle cell disease. The staff will undergo training for this study by study principal investigators which will include the target participant population, necessary steps in the navigation process and data that will be collected. In addition, they will receive brief training in supportive, listening technique. They will also be furnished with a telephone script for the initial participant contact.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Cleveland, Ohio, 44106, United States
Gregory Cooper, MD
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
5 participants (actual enrollment reported by the registry).
First Submitted
January 24, 2019
First Posted
January 28, 2019
Study Start
September 1, 2019
Actual (reported)Empowering Families of Migrant Children and Youth with Special Healthcare Needs
Contact the study team to confirm eligibility.
Primary Completion
June 30, 2020
Actual (reported)Study Completion
June 30, 2020
Actual (reported)Last Updated
June 15, 2025
Record last verified: 2025-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: